The United States represents the largest share of the Chemiluminescence Imaging System Market in North America, driven by its robust biotechnology and pharmaceutical sectors, extensive biomedical research activities, and strong funding support from government agencies and private organizations. The growing focus on precision medicine, proteomics, genomics, and cancer research has accelerated...